Several U.S.-listed stocks saw significant drops on Friday, led by the Daily Target 2X Long OKLO ETF (OKLL), which fell 18.38% due to amplified losses in Oklo Inc. shares. CPI Card Group (PMTS) declined 16.48% following a discounted secondary share offering by a major shareholder. NuScale Power (SMR) dropped 15.73% after an analyst downgrade from UBS citing weaker earnings expectations. Other biotech stocks like SELLAS Life Sciences and bioAffinity Technologies also fell amid volatility and unclear negative factors. These declines highlight the impact of leverage, share offerings, and analyst sentiment on market movements.
Oklo Inc's shares fell over 7% following the launch of a new $1 billion at-the-market (ATM) stock offering. This comes after the company fully utilized its previous $1 billion ATM program within four months, selling nearly 18 million shares at an ave...
NuScale Power's stock dropped 5% following UBS's downgrade from Neutral to Sell and a price target cut to $6, citing concerns over a construction timeline exceeding five years, lack of firm customer contracts, and projected $700 million cash burn ove...
Investment firm UBS downgraded NuScale Power's stock rating from Neutral to Sell on September 11, 2026, citing shifting market trends in the advanced nuclear energy sector. This downgrade contributed to a 5.6% drop in NuScale's stock price, reflectin...
Shares of advanced nuclear companies Oklo, NuScale Power, and X-Energy each dropped about 5% following Piper Sandler's split rating on the sector, with Oklo receiving a Buy rating and X-Energy a Sell. The sell-off reflects market caution despite fede...
Stocks of small modular reactor developers NuScale Power and Oklo rose sharply by 13% and 7% respectively, signaling renewed investor interest in the nuclear energy sector despite a broadly declining market. This rally comes without new company-speci...
